OPIANT PHARMACEUTICALS INC (OPNT)
US6837501039 - Common Stock
Opiant Pharmaceuticals Announces CFIUS Approval for Proposed Acquisition by Indivior PLC
Opiant Pharmaceuticals Announces CFIUS Approval for Proposed Acquisition by Indivior PLC
CFIUS clearance represents the final required regulatory approval to complete the proposed mergerCompletion remains subject to the approval of Opiant...
Opiant Pharmaceuticals Announces Expiration of Hart-Scott-Rodino Waiting Period for Proposed Acquisition by Indivior PLC
Opiant Pharmaceuticals Announces Expiration of Hart-Scott-Rodino Waiting Period for Proposed Acquisition by Indivior PLC
SANTA MONICA, Calif., Feb. 06, 2023 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals Inc. (NASDAQ: OPNT) announced today the expiration of the waiting period...
Horizon, Opiant stock fall on report Elizabeth Warren concerned about pharma deals
Horizon Pharmaceuticals (HZNP) dropped on a report that Sen. Elizabeth Warrenhas concerns about Amgen's (AMGN) plan to buy Horizon Therapeutics (HZNP) and Indivior plan to acquire Opiant
Horizon, Opiant stock fall amid Elizabeth Warren concerned about pharma deals
Horizon Pharmaceuticals (HZNP) dropped on a report that Sen. Elizabeth Warrenhas concerns about Amgens (AMGN) plan to buy Horizon Therapeutics (HZNP) and Indivior plan to acquire Opiant
Opiant wins FDA priority review for opioid overdose therapy (NASDAQ:OPNT)
Opiant Pharmaceuticals (OPNT) announced the FDA accepted its New Drug Application ((NDA)) for nasal opioid overdose therapy OPNT003, with a PDUFA date on May 22. Read the full story here.
Opiant Pharmaceuticals Announces FDA Acceptance and Priority Review of NDA for OPNT003, Nasal Nalmefene, for Opioid Overdose
Opiant Pharmaceuticals Announces FDA Acceptance and Priority Review of NDA for OPNT003, Nasal Nalmefene, for Opioid Overdose
FDA sets PDUFA date of May 22, 2023 SANTA MONICA, Calif., Jan. 19, 2023 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT) today...
SHAREHOLDER ALERT: Weiss Law Reminds EQ, IMGO, MTCR, and OPNT Shareholders About Its Ongoing Investigations
/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...
SHAREHOLDER ALERT: Weiss Law Reminds EQ, IMGO, MTCR, and OPNT Shareholders About Its Ongoing Investigations
/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...
Indivior Capital Markets Day Highlights Strategy for Shareholder Value Creation and Attractive Medium-Term Profitable Growth Outlook
/PRNewswire/ -- Indivior PLC (LON: INDV) will hold a Capital Markets Day today in New York City. The event will be hosted by Mark Crossley, Chief Executive...
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ELVT, OPNT, BNFT, ABMD
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RBA, WAFD, OPNT, GRAY
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
SHAREHOLDER ALERT: Weiss Law Reminds EQ, IMGO, MTCR, and OPNT Shareholders About Its Ongoing Investigations
/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...
SHAREHOLDER ALERT: Weiss Law Reminds OPNT, WAFD, MYOV, and KNBE Shareholders About Its Ongoing Investigations
/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...
Opiant Pharmaceuticals Announces Completion of Rolling NDA Submission for OPNT003, Nasal Nalmefene, for Opioid Overdose
SANTA MONICA, Calif., Nov. 22, 2022 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT) today announced it has completed...
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ELVT, IMGO, GRAY, OPNT
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
SHAREHOLDER ALERT: Weiss Law Reminds OPNT, WAFD, MYOV, and KNBE Shareholders About Its Ongoing Investigations
/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...
SHAREHOLDER ALERT: Weiss Law Investigates Opiant Pharmaceuticals, Inc.
/PRNewswire/ -- Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Opiant Pharmaceuticals,...
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates OPNT, WAFD, LBC
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
Party City Layoffs 2022: What to Know About the PRTY Job Cuts
Party City (PRTY) is the latest company to announce layoffs as it prepares to cut 19% of its workforce due to rising inflation.
Why Is Opiant Pharma (OPNT) Stock Up 116% Today?
Opiant Pharmaceuticals (OPNT) stock is rocketing higher on Monday following news that Indivior is acquiring the Narcan maker!
Shareholder Alert: Ademi LLP investigates whether Opiant Pharmaceuticals Inc. has obtained a Fair Price in its transaction with Indivior
/PRNewswire/ -- Ademi LLP is investigating Opiant (NASDAQ: OPNT) for possible breaches of fiduciary duty and other violations of law in its transaction with...